AR017127A1 - Nuevos compuestos de piperazina y piperidina, un metodo para su preparacion, composiciones farmaceuticas que las contienen, metodos para prepararlas y nuevos compuestos intermedios para dicho metodo. - Google Patents

Nuevos compuestos de piperazina y piperidina, un metodo para su preparacion, composiciones farmaceuticas que las contienen, metodos para prepararlas y nuevos compuestos intermedios para dicho metodo.

Info

Publication number
AR017127A1
AR017127A1 ARP980104704A ARP980104704A AR017127A1 AR 017127 A1 AR017127 A1 AR 017127A1 AR P980104704 A ARP980104704 A AR P980104704A AR P980104704 A ARP980104704 A AR P980104704A AR 017127 A1 AR017127 A1 AR 017127A1
Authority
AR
Argentina
Prior art keywords
new
alkyl
compounds
group
alkoxy
Prior art date
Application number
ARP980104704A
Other languages
English (en)
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of AR017127A1 publication Critical patent/AR017127A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La invencion se refiere a un nuevo grupo de compuestos de piperazina y piperidina que tienen propiedades farmacologicamente interesantes. Se encontroque compuestos de formula (a) en donde A representa un anillo heterocíclico de 5 a 7 átomos quecompr ende 1 a 3 heteroátomos del grupo formado por O, N yS; R1 es hidrogeno o fluor; R2 es alquilo C1-4, alcoxi C1-4 o un grupo oxo, y p es 0, 1 o 2; Z representa carbono o nitrogeno, y la línea punteada es unaligadura simple si Z es nitrogeno, yuna liga dura simple o doble si Z es carbono; R3 y R4 son independientemente hidrogeno o alquilo C1-4; n tiene el valorde 1 o 2; R5 es 2-piridilo o 4-piridilo sustituidos en la posicion meta con respecto al puente de metileno con un grupo Y, yopcionalmente s ustituidos con(R6)q; Y es fenilo, furanilo o tienilo, grupos que pueden estar sustituidos con 1 a 3 sustituyentes del grupo formado por hidroxi, halogeno, CF3, alcoxi C1-4,alquilo C1-4, ciano, aminocarbonilo, mono- o di-(alquil C1-4)aminocarbonilo; R6 es halogeno, hidroxi, alcoxi C1-4 o alquilo C1-4, y q es 0, 1 2 o 3 y salesde los mismos tienen propiedades farmacologicas interesantes. La invencion se refiere también a un método para la preparacion de dichos nuevoscompuestos, acomposiciones fa rmacéuticas que las contienen, a métodos para prepararlas y a nuevos compuestos intermedios para dicho método.
ARP980104704A 1997-09-24 1998-09-21 Nuevos compuestos de piperazina y piperidina, un metodo para su preparacion, composiciones farmaceuticas que las contienen, metodos para prepararlas y nuevos compuestos intermedios para dicho metodo. AR017127A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202950 1997-09-24

Publications (1)

Publication Number Publication Date
AR017127A1 true AR017127A1 (es) 2001-08-22

Family

ID=8228755

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104704A AR017127A1 (es) 1997-09-24 1998-09-21 Nuevos compuestos de piperazina y piperidina, un metodo para su preparacion, composiciones farmaceuticas que las contienen, metodos para prepararlas y nuevos compuestos intermedios para dicho metodo.

Country Status (31)

Country Link
US (2) US6090812A (es)
EP (1) EP0908458B1 (es)
JP (1) JP4191826B2 (es)
KR (1) KR100632188B1 (es)
CN (1) CN1093857C (es)
AR (1) AR017127A1 (es)
AT (1) ATE316529T1 (es)
AU (1) AU733526B2 (es)
BR (1) BR9803497A (es)
CA (1) CA2247734C (es)
CY (1) CY1107494T1 (es)
CZ (1) CZ296741B6 (es)
DE (1) DE69833297T2 (es)
DK (1) DK0908458T3 (es)
DZ (1) DZ2613A1 (es)
ES (1) ES2255127T3 (es)
HK (1) HK1018272A1 (es)
HU (1) HU227422B1 (es)
ID (1) ID20895A (es)
IL (1) IL126295A (es)
NO (1) NO312835B1 (es)
NZ (1) NZ331984A (es)
PL (1) PL190622B1 (es)
PT (1) PT908458E (es)
RU (1) RU2197488C2 (es)
SI (1) SI0908458T1 (es)
SK (1) SK285205B6 (es)
TR (1) TR199801866A1 (es)
TW (1) TW530054B (es)
UA (1) UA66756C2 (es)
ZA (1) ZA988749B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200994B1 (en) 1999-01-07 2001-03-13 American Home Products Corp 1,4-Disubstituted cyclohexane derivatives for the treatment of depression
AU2494400A (en) * 1999-01-07 2000-07-24 American Home Products Corporation New 1,4-disubstituted cyclohexane derivatives for the treatment of depression
DE10005150A1 (de) * 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
EP2024363B1 (en) 2006-05-02 2012-08-01 Abbott Healthcare Products B.V. N-oxides of pyridylmethylpiperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
WO2011088838A1 (en) 2010-01-25 2011-07-28 H. Lundbeck A/S Novel 6,6a,7,8,9,10-hexahydro-4h-4,8,10a-triaza-acephenanthrylene derivatives as dopamine d2 ligands
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
TWI712598B (zh) 2016-07-20 2020-12-11 瑞士商諾華公司 胺基吡啶衍生物及其作為選擇性alk-2抑制劑之用途
KR101665971B1 (ko) 2016-08-10 2016-10-13 (주)글로벌 로보틱스 차량용 발포패드 부착장치
EP4061367A1 (en) 2019-11-22 2022-09-28 Incyte Corporation Combination therapy comprising an alk2 inhibitor and a jak2 inhibitor
AU2021292484A1 (en) 2020-06-16 2023-01-19 Incyte Corporation ALK2 inhibitors for the treatment of anemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
ATE44528T1 (de) * 1984-12-21 1989-07-15 Duphar Int Res Arzneimittel mit antipsychotischer wirkung.
PH22783A (en) * 1986-02-27 1988-12-12 Duphar Int Res New aryl-substituted (n-piperidinyl)methyl-and (n-piperazinyl)methylazoles and pharmaceutical compositions containing the same
EP0508347A1 (en) 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
JPH05262765A (ja) 1992-03-18 1993-10-12 Sumitomo Chem Co Ltd ベンゾフラン誘導体およびそれを有効成分とする除草剤
FR2692264B1 (fr) 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5332732A (en) * 1992-09-11 1994-07-26 Mcneilab, Inc. Thiophene and pyridine antipsychotic agents
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
EP0650964A1 (en) 1993-11-02 1995-05-03 Duphar International Research B.V 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
AU6517196A (en) * 1995-07-13 1997-02-10 Knoll Aktiengesellschaft Piperazine derivatives as therapeutic agents
IL126187A0 (en) * 1996-03-29 1999-05-09 Duphar Int Res Piperazine and piperidine compounds
DE19637237A1 (de) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate

Also Published As

Publication number Publication date
NO312835B1 (no) 2002-07-08
JPH11302279A (ja) 1999-11-02
IL126295A (en) 2003-02-12
HUP9802129A1 (hu) 2000-03-28
PL328754A1 (en) 1999-03-29
HU227422B1 (en) 2011-05-30
RU2197488C2 (ru) 2003-01-27
SK129498A3 (en) 1999-04-13
HU9802129D0 (en) 1998-11-30
DZ2613A1 (fr) 2003-03-01
HK1018272A1 (en) 1999-12-17
ID20895A (id) 1999-03-25
CA2247734A1 (en) 1999-03-24
DE69833297D1 (de) 2006-04-13
TW530054B (en) 2003-05-01
BR9803497A (pt) 2000-05-02
CY1107494T1 (el) 2013-03-13
JP4191826B2 (ja) 2008-12-03
SI0908458T1 (sl) 2006-06-30
NZ331984A (en) 2000-02-28
CN1093857C (zh) 2002-11-06
NO984380D0 (no) 1998-09-21
USRE41425E1 (en) 2010-07-06
AU8607998A (en) 1999-04-15
DK0908458T3 (da) 2006-06-06
KR19990029982A (ko) 1999-04-26
US6090812A (en) 2000-07-18
EP0908458B1 (en) 2006-01-25
PL190622B1 (pl) 2005-12-30
CN1220265A (zh) 1999-06-23
CA2247734C (en) 2007-08-07
CZ303098A3 (cs) 1999-04-14
SK285205B6 (sk) 2006-08-03
PT908458E (pt) 2006-05-31
UA66756C2 (uk) 2004-06-15
ES2255127T3 (es) 2006-06-16
IL126295A0 (en) 1999-05-09
ATE316529T1 (de) 2006-02-15
EP0908458A1 (en) 1999-04-14
ZA988749B (en) 1999-03-26
DE69833297T2 (de) 2006-07-20
AU733526B2 (en) 2001-05-17
NO984380L (no) 1999-03-25
KR100632188B1 (ko) 2007-04-25
TR199801866A1 (xx) 1999-04-21
CZ296741B6 (cs) 2006-06-14

Similar Documents

Publication Publication Date Title
AR017127A1 (es) Nuevos compuestos de piperazina y piperidina, un metodo para su preparacion, composiciones farmaceuticas que las contienen, metodos para prepararlas y nuevos compuestos intermedios para dicho metodo.
AR047056A1 (es) Derivados de pirimidinas condensadas. composiciones farmacéuticas
AR051638A1 (es) Compuestos de piperidinilo y su uso para tratar desordenes de respuesta al bloqueo de los canales de calcio tipo n
CO5570668A2 (es) Derivados triciclicos sustituidos de himbacina que son antagonistas del receptor de trombina y composiciones farmaceuticas que los contienen
AR057989A1 (es) Derivados de indol-2-il-amida 1,5-sustituida. procesos de obtencion y composiciones farmaceuticas
AR028531A1 (es) Compuestos organicos
HUP0402508A2 (hu) 1,2,3,4-Tetrahidro-izokinolin-származékok mint urotenzin II receptor antagonisták és a vegyületeket tartalmazó gyógyszerkészítmények
AR049739A1 (es) Derivados de aril-piridina
ATE293101T1 (de) Piperidine zur verwendung als orexin rezeptor antagonisten
PE20071009A1 (es) Compuestos derivados de fenoxipiperidinas como antagonistas de histamina h3
AR035369A1 (es) Derivados de tetrahidrobenzazepina composiciones farmaceuticas que los comprenden, el uso de dichos derivados en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
AR048495A1 (es) Benzoil amino heterociclicos, utiles para el tratamiento de enfermadades intermediadas por glk
NO20005166L (no) Nye benzotiofen-, benzofuran- og indolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
AR041661A1 (es) Compuestos triciclicos utiles para el tratamiento de desordenes inflamatorios y alergicos procesos para su preparacion y composiciones farmaceuticas que lo contienen
BR9708389B1 (pt) compostos de piperazina e piperidina, composições farmacêuticas.
AR036492A1 (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3, composiciones farmaceuticas y el uso de dichos inhibidores para la elaboracion de un medicamento para el tratamiento de enfermedades androgeno dependientes
AR038249A1 (es) Compuestos derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden, y uso de dichos compuestos derivados en la preparacion de un medicamento
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
AR041395A1 (es) Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla
EA200300777A1 (ru) N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов для fsad
MX9400190A (es) Derivados de tiazolidindiona, metodo para su obtencion y composicion farmaceutica que los contiene.
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
CO5601021A2 (es) Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb
NO905368D0 (no) Serotonin-antagonister, deres fremstilling og anvendelse.
RU98117621A (ru) Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт

Legal Events

Date Code Title Description
FG Grant, registration